Partners In Investing

Ben Inker reflects on GMO’s benchmark-agnostic approach to asset allocation—its origins, key lessons, and why today’s market backdrop may favor investors willing to look different.

In a new video, Tom Hancock explains where GMO is finding opportunity across quality equities today—from AI beneficiaries to health care—and why valuation and durability remain central to the strategy.

The Fed faces an emerging third mandate it never asked for: the distribution of credit. We explore how the problem is likely to unfold in two acts and what it means for portfolios.

Japan’s governance reforms are shaping a more active market for corporate control, creating opportunities for engaged investors to help protect minority shareholders and unlock long-term value.

With liquid alternatives, investors don’t have to choose between return, diversification, and liquidity. GMO explains how ALTA strives to achieve all three.

GMO's 7-Year Asset Class Forecast as of July 31, 2026.

What creates a durable edge in systematic equity investing? GMO examines the research, valuation framework, and portfolio construction behind its approach.

As the Goldilocks era ends, liquidity and true diversification matter more. GMO explores why liquid alternatives deserve a fresh look.

Surging electricity demand is reshaping the energy landscape, creating opportunities for investors across a wide variety of industries.

In GMO’s latest Quarterly Valuation Update, FX and local currency rates screen cheap and very cheap, while hard currency credit is rich.

GMO's 7-Year Asset Class Forecast as of June 30, 2026.

Emerging market debt is broad and inefficient. We examine when a total return, cash‑plus approach may better align portfolios with desired outcomes.